NLRP3 and chronic obstructive pulmonary disease: Finally, the robust results obtained here using the NLRP3 inhibitor, MCC-950, open a new therapeutic avenue for T1D induced cardiac arrhythmias, since it improves the cardiac electrical profile, while keeping other inflammasomes involved in the response to infectious diseases intact.